Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity
Elisabeth Müller(University of Oslo)
Cited by 5
Related Papers
Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
|Frontiers in Immunology|2018|127